We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck, Gnosis Settle Vitamin False Marketing Case

Law360 (March 27, 2009, 12:00 AM EDT) -- Merck Eprova and rival pharmaceutical company Gnosis SpA have settled a false advertising and unfair competition suit alleging that Gnosis violated the Lanham Act when it falsely portrayed its folate-producing compound as equivalent in potency and purity to Merck's version.

United States District Judge Richard J. Sullivan of the U.S. District Court for the Southern District of New York on Wednesday dismissed the case with prejudice but without costs, saying that either party could apply to restore the action within 30 days.

Notice of a settlement...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.